SCHEMBL12284837

SCHEMBL12284837

Cc1nc(-c2ccccc2)oc1CNC(=S)SCCC#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 6/20 0.37
▸ ALDH1A1 P00352 7/20 0.35
▸ KDM4E B2RXH2 6/20 0.35
▸ HPGD P15428 5/20 0.35
▸ HSD17B10 Q99714 4/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ PPARD Q03181 3/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ VDR P11473 4/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ THRA P10827 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ RXRA P19793 1/20 0.32
▸ PPARG P37231 1/20 0.32
▸ PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12284864 0.80 HDAC8 (0.51) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL14715069 0.71 ALDH1A1 (0.39) GAAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14715070 0.70 ALDH1A1 (0.38) GAAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14724329 0.70 ALDH1A1 (0.43) GAAALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL6377222 0.67 KDM4E (0.51) GAAKDM4EHPGDPPARDFFAR1
SCHEMBL12286028 0.66 KMT2A (0.49) GAAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14982890 0.66 SMN1; SMN2 (0.40) L3MBTL1SMN1; SMN2HTT
SCHEMBL14982897 0.66 CA9 (0.42) GAAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL4553353 0.66 GAA (0.45) GAAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL14382242 0.66 KDM4E (0.47) GAAALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2013-05-30 — — US disclosed
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2013-05-30 — — US disclosed
EP-2562157-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF Peking University (CN) 2013-02-27 — — EP disclosed
WO-2011131135-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF 北京大学 (CN) 2011-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF LTK, ERBB2, ABL1 GAA 1564/4885ALDH1A1 2942/4885KDM4E 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback